NCT00238498View on ClinicalTrials.gov

A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

291

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

vildagliptin

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY